Cargando…
Inhibition of KDM4C/c‐Myc/LDHA signalling axis suppresses prostate cancer metastasis via interference of glycolytic metabolism
Autores principales: | Lin, Ching‐Yu, Wang, Bi‐Juan, Fu, Yu‐Ke, Huo, Chieh, Wang, Ya‐Pei, Chen, Bo‐Chih, Liu, Wei‐Yi, Tseng, Jen‐Chih, Jiang, Shih Shen, Sie, Zong‐Lin, Tsai, Kelvin K, Yuh, Chiou‐Hwa, Wang, Wen‐Ching, Kung, Hsing‐Jien, Chuu, Chih‐Pin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958350/ https://www.ncbi.nlm.nih.gov/pubmed/35343073 http://dx.doi.org/10.1002/ctm2.764 |
Ejemplares similares
-
Histone Demethylase KDM4C Stimulates the Proliferation of Prostate Cancer Cells via Activation of AKT and c-Myc
por: Lin, Ching-Yu, et al.
Publicado: (2019) -
Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancer
por: Wu, Meng-Jen, et al.
Publicado: (2021) -
KDM4B is a coactivator of c-Jun and involved in gastric carcinogenesis
por: Wu, Meng-Chen, et al.
Publicado: (2019) -
Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancer
por: Liu, Jai-Shin, et al.
Publicado: (2022) -
Targeting the histone demethylase PHF8-mediated PKCα-Src-PTEN axis in HER2-negative gastric cancer
por: Tseng, Lin-Lu, et al.
Publicado: (2020)